Deep Blue Medical Advance

Durham, United States Founded: 2015 • Age: 11 yrs
Hernia mesh devices are developed to treat and prevent recurrences.
Request Access

About Deep Blue Medical Advance

Deep Blue Medical Advance is a company based in Durham (United States) founded in 2015.. Deep Blue Medical Advance has raised $18.12 million across 10 funding rounds from investors including HHS, NCBiotech and BayMed Venture Partners. Deep Blue Medical Advance offers products and services including T-LINE® Hernia Mesh, T-Line® TCS, and Anchor Clips. Deep Blue Medical Advance operates in a competitive market with competitors including TELA Bio, Via Surgical, Ariste Medical, Polytouch Medical and ArTack Medical, among others.

  • Headquarter Durham, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Deep Blue Medical Advances, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $18.12 M (USD)

    in 10 rounds

  • Latest Funding Round
    $5.26 M (USD), Series A

    Sep 09, 2025

  • Investors
    HHS

    & 2 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Deep Blue Medical Advance

Deep Blue Medical Advance offers a comprehensive portfolio of products and services, including T-LINE® Hernia Mesh, T-Line® TCS, and Anchor Clips. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Device for reinforcing tissue and reducing hernia recurrence.

Suture for quicker, safer procedures with less tissue stress.

Clips for faster implantation in hernia surgeries.

People of Deep Blue Medical Advance
Headcount 10-50
Employee Profiles 8
Employee Profiles
People
Chris Ryan
Regional Business Director
People
Lou Fuqua
VP of Operations and Quality
People
Bill Perry
CEO, Board Member
People
David Ruppert
Director Of Research Development

Unlock access to complete

Funding Insights of Deep Blue Medical Advance

Deep Blue Medical Advance has successfully raised a total of $18.12M across 10 strategic funding rounds. The most recent funding activity was a Series A round of $5.26 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 10
  • Last Round Series A — $5.3M
  • First Round

    (12 Apr 2017)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2025 Amount Series A - Deep Blue Medical Advance Valuation

investors

Jun, 2022 Amount Series A - Deep Blue Medical Advance Valuation

investors

Feb, 2021 Amount Series A - Deep Blue Medical Advance Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Deep Blue Medical Advance

Deep Blue Medical Advance has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, NCBiotech and BayMed Venture Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
BayMed Venture Partners is focused on investing in early-stage medical device and digital health companies.
Founded Year Domain Location
Biotech startups are incubated and funded in North Carolina.
Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Deep Blue Medical Advance

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Deep Blue Medical Advance

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Deep Blue Medical Advance Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Deep Blue Medical Advance

Deep Blue Medical Advance operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TELA Bio, Via Surgical, Ariste Medical, Polytouch Medical and ArTack Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of surgical devices for vertical hernia repair and abdominal wall reconstruction
domain founded_year HQ Location
Transfascial suture fixation devices for hernia repair are provided.
domain founded_year HQ Location
Drug-eluting surgical implants are developed to prevent device failure.
domain founded_year HQ Location
Laproscopic soft tissue prosthetic placement solutions
domain founded_year HQ Location
Specializes in manufacturing hernia mesh fixation devices for medical applications.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Deep Blue Medical Advance

Frequently Asked Questions about Deep Blue Medical Advance

When was Deep Blue Medical Advance founded?

Deep Blue Medical Advance was founded in 2015 and raised its 1st funding round 2 years after it was founded.

Where is Deep Blue Medical Advance located?

Deep Blue Medical Advance is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.

Is Deep Blue Medical Advance a funded company?

Deep Blue Medical Advance is a funded company, having raised a total of $18.12M across 10 funding rounds to date. The company's 1st funding round was a Series A of $3.44M, raised on Apr 12, 2017.

What does Deep Blue Medical Advance do?

Deep Blue Medical Advance was founded in 2015 and is based in Durham, United States. Operations focus on the medical device sector, where hernia mesh products such as the T-Line mesh and Anchor Clips are developed. These devices aim to lower rates of hernia occurrence and recurrence through targeted surgical applications. The company addresses ongoing challenges in hernia repair within the healthcare industry.

Who are the top competitors of Deep Blue Medical Advance?

Deep Blue Medical Advance's top competitors include TELA Bio, Via Surgical and Ariste Medical.

What products or services does Deep Blue Medical Advance offer?

Deep Blue Medical Advance offers T-LINE® Hernia Mesh, T-Line® TCS, and Anchor Clips.

Who are Deep Blue Medical Advance's investors?

Deep Blue Medical Advance has 3 investors. Key investors include HHS, NCBiotech, and BayMed Venture Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available